X-Square Capital’s Nektar Therapeutics NKTR Stock Holding History

X-Square Capital’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-867	Closed	-$9K	–	147
2023 Q1	$9K	Hold	867	–	–	0.01%	150
2022 Q4	$29K	Hold	867	–	–	0.02%	148
2022 Q3	$42K	Hold	867	–	–	0.03%	143
2022 Q2	$49K	Hold	867	–	–	0.03%	148
2022 Q1	$70K	Buy	+867	New	+$128K	0.04%	145

Other funds holding NKTR

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

X-Square Capital's NKTR Position: Q2 2023 in Review

X-Square Capital sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 867 shares — an estimated $9K sold.

X-Square Capital first reported a position in NKTR in Q1 2022 and held it in 5 quarters. The position peaked at $70K in Q1 2022. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

X-Square Capital reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
X-Square Capital sold 867 Nektar Therapeutics shares in Q2 2023, an estimated $9K.
X-Square Capital first reported a position in Nektar Therapeutics in Q1 2022 and held it in 5 quarters.
X-Square Capital's Nektar Therapeutics position peaked at $70K in Q1 2022.
146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on X-Square Capital's 13F filing for Q2 2023, filed 14 Aug 2023.